JPMorgan maintains Tesla stock underweight rating amid delivery concerns

JPMorgan reiterated its Underweight rating and $115 price target on Tesla, citing continued demand challenges and projecting Q2 deliveries to decline 19% year-over-year to 360,000 vehicles, significantly below consensus estimates. This forecast, a 9% reduction from JPM's prior estimate, underscores persistent "softer demand" observed since Q1. Despite Deutsche Bank maintaining a Buy rating, Tesla also faces a pending Autopilot lawsuit amidst advancements in charging infrastructure and autonomous driving.

Analysis

JPMorgan has reiterated a notably bearish stance on Tesla (TSLA), maintaining an "Underweight" rating and a $115 price target, which implies a significant downside from its current trading price of $317.66. The core of this thesis rests on weakening fundamentals, specifically a projected 19% year-over-year decline in second-quarter deliveries to 360,000 vehicles, a figure that is 8.3% below Bloomberg consensus and 6.5% below company-compiled consensus. This forecast highlights that the "softer demand" identified in Q1 has persisted and accelerated. While Deutsche Bank offers a contrasting "Buy" rating with a $345 target, it also anticipates a Q2 delivery miss, forecasting approximately 355,000 units. This alignment on a delivery shortfall from both a bull and a bear suggests a high probability of a negative surprise for the market. These demand-side challenges are juxtaposed with positive technological and operational developments, such as the deployment of V4 Superchargers in China and a milestone in fully autonomous driving. However, these long-term positives are tempered by a significant near-term risk, as a federal lawsuit concerning a fatal crash involving Autopilot is set for trial, introducing potential legal and reputational headwinds.

Key Decisions for Investors

• Investors should brace for potential downside volatility surrounding the official Q2 delivery announcement, as forecasts from both bullish and bearish analysts point towards a significant miss against consensus.
• Given the stock's high P/E ratio of 166 and evidence of weakening consumer demand, it may be prudent to reassess exposure, especially considering JPMorgan's price target implies substantial overvaluation at current levels.
• Monitor the upcoming Autopilot lawsuit trial as a key near-term catalyst, as an unfavorable outcome could introduce significant reputational and financial risk, potentially overshadowing positive news on innovation.